Register Now Panelists: Derrick Zhang Senior Scientist IIUS Pharmacopeia (USP) View Bio Panelist Derrick Zhang Derrick Zhang is a senior scientist II at the US Pharmacopeia...
Belgium-based UCB selected Gwinnett County, Georgia, as the location for its new U.S. biologics manufacturing facility. The campus will use a digital-first approach by leveraging AI,...
Merck & Co. has agreed to acquire Terns Pharmaceuticals for approximately $6.7 billion, the companies said today, in a deal designed to bolster the buyer’s cancer...
Modern medicine has achieved extraordinary success in treating acute disease. Yet when it comes to chronic degenerative conditions, the diseases that dominate healthcare spending and disability...
Anyone who has weathered a bad stomach bug knows the feeling: a loss of appetite that sets in and lingers, even after the initial illness. For...
It is well known that chronic inflammation can increase a person’s cancer risk, but the underlying mechanisms remain unknown. Now, a new study reveals, in a...
Artificial intelligence and machine learning (AI/ML) are breakthrough tools in biopharmaceutical processing, but they are only as good as the dynamic processes they interact with. You...
Biopharma is embracing artificial intelligence (AI), according to the European industry group, IFMPA, which points to process development and visual inspection as examples of areas where...
Host-cell proteins (HCPs) remain one of bioprocessing’s most stubborn analytical headaches. These residual impurities, shed by production cells during manufacturing, can survive purification and threaten both...
During a gathering of Massachusetts political and company officials earlier this week, Rentschler Biopharma, a CDMO headquartered in Laupheim, Germany, cited the continued evolution and progress...